A final flurry of activity in December rounded off 2016 with a tally of 174 medtech M&A deals, a year-on-year decline from the 237 deals tracked by Medtech Insight in 2015 and 269 in 2014. But while
Financings Life science start-up companies raised a total of $1.8 billion in the first quarter of 2016, $579 million less than the previous quarter. Thirty-seven biopharma companies combined for $1.3
IN VITRO DIAGNOSTICS Mergers & Acquisitions Abbott Laboratories Inc. Alere Inc. Abbott Laboratories Inc. is paying $56 per share (a 50% premium) or $5.8bn to acquire fellow public firm Alere Inc